Navigation Links
Amgen Oncology Data to be Presented at ASCO Annual Meeting
Date:5/18/2011

ts with active malignant disease receiving neither chemotherapy nor radiation therapy; ESAs are not indicated for use in this patient population.

In some clinical situations blood transfusion should be the preferred treatment for the management of anaemia in patients with cancer. The decision to administer recombinant erythropoietins should be based on a benefit-risk assessment with the participation of the individual patient, which should take into account the specific clinical context. Factors that should be considered in this assessment should include the type of tumour and its stage; the degree of anaemia; life-expectancy; the environment in which the patient is being treated; and patient preference.

In patients with solid tumours or lymphoproliferative malignancies, if Hb >12 g/dL, the dose should be reduced/held to minimise the potential risk of thromboembolic events.

Discontinue use after the end of chemotherapy.

About AmgenAmgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and vital medicines, visit www.amgen.com.

Forward-Looking StatementsThis statement contains forward-looking statements that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference
2. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
3. Amgen to Present at the Deutsche Bank 36th Annual Healthcare Conference
4. Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
5. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
6. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
7. Amgen to Webcast 2011 Business Review Meeting on April 21
8. Amgen Announces Webcast of 2011 First Quarter Financial Results
9. Amgen Establishes Commercial Operations in Brazil
10. Amgen to Appeal CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe
11. Amgen Donates $1 Million to Help Japanese Disaster Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... market has witnessed robust development with the growth pace keeping ... starter. In 2012, the size of China ... proportion worldwide soaring to 16.3%. It is projected that ... growth rate by around 20% in the upcoming years and ... billion. An integrated membrane industrial system has taken ...
(Date:12/17/2014)... , Dec. 17, 2014  Strategic Health Services, ... software solutions, today announced a strategic agreement with QualCare, ... New Jersey regional marketplace.  This agreement ... the health and wellness solutions QualCare brings to its ... the surrounding region. QualCare plans cover ...
(Date:12/17/2014)... -- , The new Dompé ... information concerning the biopharmaceutical Group,s national and international clinical research ... the recently launched institutional website that is receiving accolades from ... a new chapter in the fascinating story of Drug Discovery ... panoramic hub on the world of clinical research, ranging from ...
Breaking Medicine Technology:Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 2Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions 3Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3
... 2012 Reportlinker.com announces that a new ... catalogue:   ... Devices http://www.reportlinker.com/p0799254/Pricing-and-Reimbursement-Strategies-for-Medical-Devices.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Facility ... medical devices being purchased within public healthcare ...
... Therapeutics, LLC, a clinical-stage biopharmaceutical company developing novel ... the TREAT-NMD Advisory Committee on Therapeutics (TACT) has ... dystrophy (DMD), and believes the compound has potential ... global network dedicated to expediting the delivery of ...
Cached Medicine Technology:Pricing and Reimbursement Strategies for Medical Devices 2Pricing and Reimbursement Strategies for Medical Devices 3Pricing and Reimbursement Strategies for Medical Devices 4Halo Therapeutics Reports Favorable Independent Review of Lead Drug Candidate HT-100 2Halo Therapeutics Reports Favorable Independent Review of Lead Drug Candidate HT-100 3
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- New research warns parents that ... lives at risk. Nearly half of teen drivers killed in ... were at least 11 years old and often lacked important safety ... Eighty-two percent of teen drivers killed in crashes were in cars ... to 10 years old, 31 percent were in cars 11 to ...
(Date:12/19/2014)... News) -- Injectable drug users who also use cocaine ... of other substance users, a new study finds. ... risk of suicide attempt and completed suicide," Didier Jutras-Aswad, ... in a university news release. "However, there are many ... who among substance users were actually more likely to ...
(Date:12/19/2014)... Raleigh, NC (PRWEB) December 19, 2014 Surviving ... asbestos and EPA information indicates that these pipes can leach ... to go to the full story on the Surviving ... to the erosion of natural asbestos deposits, decaying water mains ... in drinking water. , To protect consumers from ...
(Date:12/19/2014)... Kan. (PRWEB) December 19, 2014 B. ... exclusively to healthcare providers, has been retained to lead ... Johnson Memorial Hospital in Franklin, Ind. The top executive ... has recently placed more than 900 healthcare executives into ... county-owned, full service hospital providing care to the residents ...
(Date:12/19/2014)... Pain Free Living a leader in the ... new Superior magnetic necklace using ion neodymium ... neodymium magnets for the fastest pain relief in a ... Magnetics brand for the fastest relief by using 5200 ... using Superior Magnetic Jewelry at fairs and festivals” explained ...
Breaking Medicine News(10 mins):Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3Health News:New Superior Magnetic Necklace Relieves Migraine Headache 2
... Only program that facilitates creation of a 3D model ... N.Y., Feb. 18 /PRNewswire/ -- ... technology that enables orthodontists to create an accurate 3D ... single impression. Combining advanced CT scanning technology with GAC,s ...
... Outgoing Cabinet Head and Former Utah Governor to Provide ... ReformORLANDO, Fla., Feb. 18 ConnextionsHealth announced today that ... Services under President George W. Bush from 2005 to ... address the World Health Care Congress Leadership Summit on ...
... N.C. A widely used blood pressure medication may ... after radiation treatment, according to a newly published study ... The findings offer the hope of an improved ... rat model, the study drew on a hypothesis from ...
... journal Nature Genetics have for the first ... attack and coronary heart disease. In one of the ... the Myocardial Infarction Genetics Consortium identified nine precise genes ... of them newly discovered; the investigators said that these ...
... to Providing High Quality Services to the CommunityLOS ... ("Avanti") is pleased to announce that it has ... Gardena ("MHG") and East Los Angeles Doctors Hospital ... been providing quality acute and sub-acute healthcare services ...
... -- Medical travel company Companion Global ... and U.S. employer groups now have additional options ... care while remaining closer to home.Companion Global Healthcare ... the CIMA Hospitals in Hermosillo, Mexico, and Monterrey, ...
Cached Medicine News:Health News:OrthoPlex 3D Digital Modeling Solution Introduced by Dentsply GAC 2Health News:Former Health & Human Services Secretary Michael Leavitt to Address Health Plan Member Retention Summit 2Health News:Former Health & Human Services Secretary Michael Leavitt to Address Health Plan Member Retention Summit 3Health News:Blood pressure compound may benefit brain tumor patients 2Health News:Blood pressure compound may benefit brain tumor patients 3Health News:New genomic markers associated with risk of heart disease and early heart attack 2Health News:Avanti Health System Acquires Two Los Angeles Hospitals 2Health News:Avanti Health System Acquires Two Los Angeles Hospitals 3Health News:Avanti Health System Acquires Two Los Angeles Hospitals 4Health News:Companion Global Healthcare Expands Service to Include Hospitals in Mexico 2